Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 22.66B | 22.45B | 22.19B | 21.71B | 21.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.66B | 22.45B | 22.19B | 21.71B | 21.23B |
| Cost of Revenue | 16.69B | 16.62B | 16.49B | 16.28B | 15.99B |
| Gross Profit | 5.97B | 5.83B | 5.69B | 5.43B | 5.24B |
| SG&A Expenses | 3.47B | 3.51B | 3.43B | 3.41B | 3.42B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -2.48M | -26.44M | -37.46M | -35.73M | -83.14M |
| Total Operating Expenses | 20.34B | 20.28B | 20.06B | 19.83B | 19.51B |
| Operating Income | 2.32B | 2.16B | 2.13B | 1.87B | 1.72B |
| Income Before Tax | 1.75B | 1.70B | 1.72B | 1.32B | 1.27B |
| Income Tax Expenses | 366.36M | 350.70M | 364.92M | 306.03M | 346.20M |
| Earnings from Continuing Operations | 1.38K | 1.35K | 1.36K | 1.02K | 924.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -290.93M | -257.31M | -242.44M | -209.80M | -204.39M |
| Net Income | 1.09B | 1.10B | 1.12B | 807.38M | 720.31M |
| EBIT | 2.32B | 2.16B | 2.13B | 1.87B | 1.72B |
| EBITDA | 3.78B | 3.61B | 3.55B | 3.30B | 3.14B |
| EPS Basic | 3.88 | 3.80 | 3.85 | 2.76 | 2.45 |
| Normalized Basic EPS | 3.47 | 3.36 | 3.30 | 2.88 | 2.54 |
| EPS Diluted | 3.87 | 3.80 | 3.84 | 2.75 | 2.45 |
| Normalized Diluted EPS | 3.47 | 3.36 | 3.30 | 2.88 | 2.54 |
| Average Basic Shares Outstanding | 1.12B | 1.15B | 1.16B | 1.17B | 1.17B |
| Average Diluted Shares Outstanding | 1.12B | 1.15B | 1.16B | 1.17B | 1.17B |
| Dividend Per Share | 1.73 | 1.73 | 1.73 | 1.54 | 1.54 |
| Payout Ratio | 42.56% | 43.78% | 42.94% | 59.39% | 66.57% |